{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:40:16Z","timestamp":1759333216830},"reference-count":35,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2002,12,11]],"date-time":"2002-12-11T00:00:00Z","timestamp":1039564800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J of Med Genetics Pt A"],"published-print":{"date-parts":[[2003,5,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Homocysteine (Hcy) is converted to cysteine or is remethylated to methionine by methylenetetrahydrofolate reductase (MTHFR). MTHFR plays a central role in the metabolism of folate. Two common polymorphisms in the <jats:italic>MTHFR<\/jats:italic> gene (C677T and A1298C) have been described and studies suggest that these polymorphisms are positively associated with the occurrence of spina bifida (SB). Among Brazilians, the incidence of 677T allele homozygosity is 4%. We compared Hcy levels with the genotypes obtained for the mutations C677T and A1298C in the gene <jats:italic>MTHFR<\/jats:italic>. Levels of plasma Hcy were higher in children with SB than in controls (average 7.95 vs. 5.55 (\u03bcmol\/L); <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). There was no significant difference in the levels of Hcy for these childrens's mothers and controls (average 7.76 vs. 8.36 (\u03bcmol\/L); <jats:italic>P<\/jats:italic>\u2009=\u20090.27). Eighty one (61.8%) of the affected children were white and 50 (38.2%) were non\u2010white. A similar ratio was observed in the mothers. In the control group, 51 children (40.5%) were white and 75 (59.5%) were non\u2010white, and 52 mothers (41.3%) were white and 74 (58.7%) were non\u2010white. There was no significant difference in the homozygous frequency for the mutated allele 677T among different racial groups. We obtained a prevalence of TT homozygosity of 10\/131 (7.64%) in affected children and 13\/126 (10.32%) in controls. With respect to the mutation A1298C, the homozygous prevalence for the wild allele was greater among non\u2010white individuals than in white individuals both in case and control groups. Hyperhomocysteinemia is a risk factor for SB. However, in our population, the increase in plasma levels of Hcy is not explained by the presence of the homozygous TT. It is possible that low folic acid intake combined with other genetic factors plays a more important role in the cause of this disease. \u00a9 2003 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ajmg.a.10059","type":"journal-article","created":{"date-parts":[[2003,4,17]],"date-time":"2003-04-17T10:01:57Z","timestamp":1050573717000},"page":"20-25","source":"Crossref","is-referenced-by-count":38,"title":["Methylenetetrahydrofolate reductase (MTHFR): incidence of mutations C677T and A1298C in Brazilian population and its correlation with plasma homocysteine levels in spina bifida"],"prefix":"10.1002","volume":"119A","author":[{"given":"Ana Beatriz Alvarez","family":"Perez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e2nia","family":"D'Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naja","family":"Vergani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan C.","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda Teresa","family":"de Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Decio","family":"Brunoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,12,11]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1055\/s-0038-1656059","article-title":"The mutation Ala677\u2009\u2192\u2009Val in the methylene tetrahydrofolate reductase gene: A risk factor for arterial disease and venous thrombosis","volume":"77","author":"Arruda VR","year":"1997","journal-title":"Thromb Hemost"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19980724)78:4<332::AID-AJMG5>3.0.CO;2-N"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a010290"},{"issue":"8","key":"e_1_2_6_5_1","first-page":"415","article-title":"Alto risco gen\u00e9tico. Aspectos neonatais","author":"Brunoni D","year":"1986","journal-title":"Pediatria Moderna"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320220406"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.269.10.1233"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-8981(01)00764-1"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199212243272602"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.35.12.1009"},{"key":"e_1_2_6_11_1","volume-title":"Epi Info, version 6: A word processing, database, and statistics program for epidemiology on microcomputers","author":"Dean AG","year":"1994"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-2115(96)02620-6"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1614230"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng0595-111"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19991119)87:2<197::AID-AJMG15>3.0.CO;2-M"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng0694-195"},{"key":"e_1_2_6_17_1","first-page":"1052","article-title":"Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype\/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency","volume":"56","author":"Goyette P","year":"1995","journal-title":"Am J Hum Genet"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1086\/303082"},{"key":"e_1_2_6_19_1","first-page":"546","article-title":"Intermediate homocysteinemia resulting from compound heterozygosity for methylenetetrahydrofolate reductase mutations","volume":"48","author":"Kang S","year":"1991","journal-title":"Am J Hum Genet"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004310050860"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/16.3.1215"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90165-5"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004390050544"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)64382-6"},{"key":"e_1_2_6_25_1","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/clinchem\/45.2.290","article-title":"Rapid and accurate HPLC assay for plasma total homocysteine and cysteine in a clinical laboratory setting","volume":"45","author":"Pfeiffer CM","year":"1999","journal-title":"Clin Chem"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19991008)86:4<380::AID-AJMG13>3.0.CO;2-9"},{"issue":"3","key":"e_1_2_6_27_1","first-page":"171","article-title":"Molecular genetic aspects of hyperhomocysteinemia and its relation to folic acid","volume":"19","author":"Rozen R","year":"1996","journal-title":"Clin Invest Med"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.nutr.19.1.217"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1086\/302310"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0004.1999.560208.x"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19991105)87:1<23::AID-AJMG5>3.0.CO;2-E"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9926(199905)59:5<331::AID-TERA4>3.0.CO;2-L"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91743-8"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1086\/301825"},{"key":"e_1_2_6_35_1","first-page":"763","article-title":"A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects","volume":"88","author":"Whitehead AS","year":"1995","journal-title":"Q J Med"},{"key":"e_1_2_6_36_1","unstructured":"WHO.1993.Hereditary Diseases Programme: Guidelines for the development of national programmes for monitoring birth defects. pp11\u201312. WHO\/HDP\/ICBDMS\/GL\/93.4 (54pp)."}],"container-title":["American Journal of Medical Genetics Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajmg.a.10059","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajmg.a.10059","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T08:30:01Z","timestamp":1697617801000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajmg.a.10059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12,11]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,5,15]]}},"alternative-id":["10.1002\/ajmg.a.10059"],"URL":"https:\/\/doi.org\/10.1002\/ajmg.a.10059","archive":["Portico"],"relation":{},"ISSN":["1552-4825","1552-4833"],"issn-type":[{"value":"1552-4825","type":"print"},{"value":"1552-4833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,12,11]]}}}